TY - JOUR
T1 - Altered myofilament stoichiometry in response to heart failure in a cardioprotective α-myosin heavy chain transgenic rabbit model
AU - Stanley, Brian A.
AU - Graham, David R.
AU - James, Jeanne
AU - Mitsak, Megan
AU - Tarwater, Patrick M.
AU - Robbins, Jeff
AU - Van Eyk, Jennifer E.
N1 - Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2011/4
Y1 - 2011/4
N2 - Purpose: Decreases in α myosin heavy chain (α-MHC) is a common feature of human heart failure (HF), whereas α-MHC overexpression in transgenic (TG) rabbits is cardioprotective against tachycardia-induced cardiomyopathy (TIC). Hypothesizing that MHC isoform content alterations would impact sarcomere and mitochondrial energetics protein complement, we investigated the impact of α-MHC overexpression on global cardiac protein expression. Experimental design: Protein expression was assessed by two-dimensional gel electrophoresis and MS on the extracts from TG and nontransgenic (NTG) rabbits under TIC or sham-operated conditions. Results: We observed significant changes in the levels of actin, myosin light chain 2, and desmin between the left ventricular (LV) tissue of TG and NTG animals. The proteome was broadly impacted, with significant changes in mitochondrial energetics and chaperone protein families. No changes were observed in total cellular MHC or in myofibril-associated MHC. In myofibrils isolated from TGsham animals, only actin levels were altered in TGsham compared with NTGsham animals, suggesting careful myofibril assembly regulation. Conclusions and clinical Relevance: These data suggest that myofibril protein composition may protect against TIC, emphasizing protein interconnectivity and demonstrating the need for broad-based proteomic studies in understanding targeted genetic manipulations. This study identifies the targets for future development of cardioprotective agents and elucidates tachycardia-induced heart failure pathways.
AB - Purpose: Decreases in α myosin heavy chain (α-MHC) is a common feature of human heart failure (HF), whereas α-MHC overexpression in transgenic (TG) rabbits is cardioprotective against tachycardia-induced cardiomyopathy (TIC). Hypothesizing that MHC isoform content alterations would impact sarcomere and mitochondrial energetics protein complement, we investigated the impact of α-MHC overexpression on global cardiac protein expression. Experimental design: Protein expression was assessed by two-dimensional gel electrophoresis and MS on the extracts from TG and nontransgenic (NTG) rabbits under TIC or sham-operated conditions. Results: We observed significant changes in the levels of actin, myosin light chain 2, and desmin between the left ventricular (LV) tissue of TG and NTG animals. The proteome was broadly impacted, with significant changes in mitochondrial energetics and chaperone protein families. No changes were observed in total cellular MHC or in myofibril-associated MHC. In myofibrils isolated from TGsham animals, only actin levels were altered in TGsham compared with NTGsham animals, suggesting careful myofibril assembly regulation. Conclusions and clinical Relevance: These data suggest that myofibril protein composition may protect against TIC, emphasizing protein interconnectivity and demonstrating the need for broad-based proteomic studies in understanding targeted genetic manipulations. This study identifies the targets for future development of cardioprotective agents and elucidates tachycardia-induced heart failure pathways.
KW - MS
KW - Myofilament
KW - Two-dimensional gel
KW - α Myosin heavy chain
UR - http://www.scopus.com/inward/record.url?scp=79953092820&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79953092820&partnerID=8YFLogxK
U2 - 10.1002/prca.201000116
DO - 10.1002/prca.201000116
M3 - Article
C2 - 21365772
AN - SCOPUS:79953092820
VL - 5
SP - 147
EP - 158
JO - Proteomics - Clinical Applications
JF - Proteomics - Clinical Applications
SN - 1862-8346
IS - 3-4
ER -